Syndax Pharmaceuticals (SNDX) PT Raised to $46 at Stifel

May 1, 2026 4:10 PM

Stifel analyst Stephen Willey raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $46.00 (from $45.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found